Paragon Vial Caps Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 02-01-2025
- Paid Up Capital ₹ 2.92 M
as on 02-01-2025
- Company Age 31 Year, 8 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.64 Cr
as on 02-01-2025
- Satisfied Charges ₹ 8.45 Cr
as on 02-01-2025
- Revenue 25.68%
(FY 2022)
- Profit 278.75%
(FY 2022)
- Ebitda -10.48%
(FY 2022)
- Net Worth 12.16%
(FY 2022)
- Total Assets 3.63%
(FY 2022)
About Paragon Vial Caps
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.92 M.
The company currently has active open charges totaling ₹13.64 Cr. The company has closed loans amounting to ₹8.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Allwyn Dsouza, Raphael Lobo, Tukaram Suryakanth, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239KA1994PTC015102
- Company No.
015102
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 1994
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- LocationBangalore, Karnataka
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Paragon Vial Caps?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Steven Lobo  | Managing Director | 15-Nov-1996 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raphael Lobo | Director | 26-Jun-2017 | Current |
| Allwyn Dsouza | Director | 04-Jan-1994 | Current |
| Tukaram Suryakanth | Director | 04-Jan-1994 | Current |
Financial Performance of Paragon Vial Caps.
Paragon Vial Caps Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.68% increase. The company also saw a substantial improvement in profitability, with a 278.75% increase in profit. The company's net worth Soared by an impressive increase of 12.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Paragon Vial Caps?
In 2022, Paragon Vial Caps had a public holding of 0.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Sep 2024 | ₹2.50 M | Open |
Others Creation Date: 19 Jan 2024 | ₹6.00 M | Open |
Others Creation Date: 30 Apr 2022 | ₹8.34 Cr | Open |
How Many Employees Work at Paragon Vial Caps?
Paragon Vial Caps has a workforce of 12 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paragon Vial Caps, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paragon Vial Caps's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
